Michael G. Gartside

3.6k citations

38 papers · 1.8k indexed · h-index 21

Impact in

Obstetrics and Gynecology top 5%
- Endometrial and Cervical Cancer Treatments
Cancer Research top 10%
- Cancer, Hypoxia, and Metabolism

Papers in

Parasitology 4
- Vector-borne infectious diseases 4
Oncology 9
- Pancreatic and Hepatic Oncology Research 4

Co-authors: Pamela M. Pollock Nicholas K. Hayward Paul J. Goodfellow Sara A. Byron Matthew A. Powell Candice L. Wellens Graham F. Kay Moosa Mohammadi
Journals: International Journal of Cancer (3 papers)Parasitology Research (2 papers)Cancer Research (2 papers)Oncogene (2 papers)PLoS ONE (2 papers)
Partner nations: Australia United States United Kingdom

In The Last Decade

Michael G. Gartside

38 papers receiving 1.8k citations

Peers

Countries citing papers authored by Michael G. Gartside

Since Specialization

Citations

This map shows the geographic impact of Michael G. Gartside's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael G. Gartside with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael G. Gartside more than expected).

Fields of papers citing papers by Michael G. Gartside

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael G. Gartside. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael G. Gartside. The network helps show where Michael G. Gartside may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Michael G. Gartside, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Michael G. Gartside Line = papers co-authored together Michael G. Gartside links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Elevation of fatty acid desaturase 2 in esophageal adenocarcinoma increases polyunsaturated lipids and may exacerbate bile acid‐induced DNA damage Clinical and Translational Medicine ·Jeffrey Molendijk, Cathryn M. Kolka, 岸本晃司, Sandra Brosda, Ahmed Mohamed, Alok K. Shah, Ian Brown, Mark P. Hodson, Thomas Hennessy, Guanghao Liu, Thomas Stoll, Renée S. Richards, Michael G. Gartside, Kalpana Patel, Nicholas J. Clemons, Wayne A. Phillips, Andrew P. Barbour, Johan A. Westerhuis, Michelle M. Hill	2022	14
2	Baseline neutrophil–lymphocyte ratio holds no prognostic value for esophageal and junctional adenocarcinoma in patients treated with neoadjuvant chemotherapy Diseases of the Esophagus ·Mitsuteru Hirono, B. Mark Smithers, D. C. Gotley, Sandra Brosda, Iain Thomson, Janine Thomas, Michael G. Gartside, Andrew P. Barbour	2019	5
3	The Impact of Signet Ring Cell Differentiation on Outcome in Patients with Esophageal and Gastroesophageal Junction Adenocarcinoma Annals of Surgical Oncology ·Mitsuteru Hirono, B. Mark Smithers, D. C. Gotley, Sandra Brosda, Iain Thomson, Janine Thomas, Michael G. Gartside, J. Jan B. van Lanschot, Sjoerd M. Lagarde, Bas P. L. Wijnhoven, Andrew P. Barbour	2019	14
4	POLE mutations in families predisposed to cutaneous melanoma Familial Cancer ·Lauren G. Aoude, Ellen Heitzer, Peter A. Johansson, Michael G. Gartside, Karin Wadt, Antonia L. Pritchard, Jane M. Palmer, Judith Symmons, Anne‐Marie Gerdes, Grant W. Montgomery, Nicholas G. Martin, Ian Tomlinson, Stephen Kearsey, Nicholas K. Hayward	2015	33
5	Prevalence of GermlineBAP1, CDKN2A, andCDK4Mutations in an Australian Population-Based Sample of Cutaneous Melanoma Cases Twin Research and Human Genetics ·Lauren G. Aoude, Michael G. Gartside, Peter A. Johansson, Jane M. Palmer, Judith Symmons, Nicholas G. Martin, Grant W. Montgomery, Nicholas K. Hayward	2015	19
6	Mixed lineage kinases activate MEK independently of RAF to mediate resistance to RAF inhibitors Nature Communications ·Anna A. Marusiak, Л.Н. Крикунова, Willy Hugo, Eleanor W. Trotter, María Romina Girotti, Natalie L. Stephenson, Xiangju Kong, Michael G. Gartside, Shameem Fawdar, Andrew Hudson, Wolfgang Breitwieser, Nicholas K. Hayward, Richard Marais, Roger S. Lo, John Brognard	2014	63
7	FGFR2 mutations are rare across histologic subtypes of ovarian cancer Gynecologic Oncology ·Sara A. Byron, Michael G. Gartside, Candice L. Wellens, Paul J. Goodfellow, Michael J. Birrer, Ian Campbell, Pamela M. Pollock	2010	37
8	Loss-of-Function Fibroblast Growth Factor Receptor-2 Mutations in Melanoma Molecular Cancer Research ·Michael G. Gartside, Huaibin Chen, Omar A. Ibrahimi, Sara A. Byron, Th. Jansen, Candice L. Wellens, Natasha Matthews, Laura M. Yudt, Anna V. Eliseenkova, Jinghong Ma, John A. Curtin, Evandro Lima da Silveira Batista, Ursula L. Harper, Erica L. Riedesel, Graham J. Mann, Jeffrey M. Trent, Boris C. Bastian, Paul S. Meltzer, Moosa Mohammadi, Pamela M. Pollock	2009	102
9	Inhibition of Activated Fibroblast Growth Factor Receptor 2 in Endometrial Cancer Cells Induces Cell Death Despite PTEN Abrogation Cancer Research ·Sara A. Byron, Michael G. Gartside, Candice L. Wellens, Mary A. Mallon, Zharkyn Namirovna Omurova, Matthew A. Powell, Paul J. Goodfellow, Pamela M. Pollock	2008	119
10	Global expression profiling of sex cord stromal tumors from Men1 heterozygous mice identifies altered TGF‐β signaling, decreased Gata6 and increased Csf1r expression International Journal of Cancer ·Arne W. Mould, Olga Dostálová, Natalia Papazisi, Kelly A. Loffler, Christine Biondi, Michael G. Gartside, Graham F. Kay, Nicholas K. Hayward	2008	10
11	Inhibition of FGFR2 in endometrial cancer cells induced apoptosis despite constitutive activation of the PI3K/AKT pathway. Molecular Cancer Therapeutics ·Michael G. Gartside, Sara A. Byron, Candice L. Wellens, Zharkyn Namirovna Omurova, Matthew A. Powell, Paul J. Goodfellow, Pamela M. Pollock	2007	1
12	Global expression profiling of murine MEN1‐associated tumors reveals a regulatory role for menin in transcription, cell cycle and chromatin remodelling International Journal of Cancer ·Arne W. Mould, Olga Dostálová, Natalia Papazisi, Kelly A. Loffler, Christine Biondi, Michael G. Gartside, Graham F. Kay, Nicholas K. Hayward	2007	17
13	Lack of augmentation of tumor spectrum or severity in dual heterozygous Men1 and Rb1 knockout mice Oncogene ·Kelly A. Loffler, Christine Biondi, Michael G. Gartside, Natalia Papazisi, Robin E. Duncan, Ian D. Tonks, Arne W. Mould, Paul Waring, H. Konrad Muller, Graham F. Kay, Nicholas K. Hayward	2006	25
14	Identification of FGFR2 as a novel melanoma oncogene Cancer Research ·Michael G. Gartside, Th. Jansen, Laura M. Yudt, Ursula L. Harper, Natasha Matthews, Sandra Pavey, Ralph J. Tuthill, Boris C. Bastian, Paul S. Meltzer, Pamela M. Pollock	2005	1
15	Association Between Chronic Fatigue Syndrome and the Corticosteroid‐Binding Globulin Gene ALA SER²²⁴Polymorphism Endocrine Research ·David J. Torpy, Anthony W. Bachmann, Michael G. Gartside, Jeffrey E. Grice, Jonathan M. Harris, Peter Clifton, Simon Easteal, Richard V. Jackson, Judith A. Whitworth	2004	28
16	Targeting and conditional inactivation of the murine Men1 locus using the Cre recombinase: loxP System genesis ·Christine Biondi, Michael G. Gartside, Ian D. Tonks, Carol Paterson, Nicholas K. Hayward, Graham F. Kay	2002	20
17	A PCR‐based method of screening individuals of all ages, from neonates to the elderly, for familial hyperaldosteronism type I Australian and New Zealand Journal of Medicine ·Michael Stowasser, Michael G. Gartside, Richard D. Gordon	1997	30
18	Evidence for persistent dysfunction of wild-type aldosterone synthase gene in glucocorticoid-treated familial hyperaldosteronism type I Journal of Hypertension ·Michael Stowasser, Angela Y. Douglas, Michael G. Gartside, Terry J. Tunny, Richard D. Gordon	1997	9
19	Increased resistance to Anaplasma marginale infection in cattle chronically infected with Theileria buffeli (syn. T. orientalis) Veterinary Parasitology ·K. R. Gale, G. Leatch, Christine M. Dimmock, Michael G. Gartside	1997	5
20	Anaplasma marginale: failure of sera from immune cattle to confer protection in passive-transfer experiments Parasitology Research ·K. R. Gale, G. Leatch, Michael G. Gartside, Christine M. Dimmock	1992	27

About Michael G. Gartside

Michael G. Gartside is a scholar working on Parasitology, Oncology, Endocrinology, Diabetes and Metabolism, Behavioral Neuroscience and Molecular Biology, having authored 38 papers that have together received 1.8k indexed citations. Recurring topics across this work include Fibroblast Growth Factor Research (9 papers), Neuroendocrine Tumor Research Advances (6 papers), Hormonal Regulation and Hypertension (5 papers), Pancreatic and Hepatic Oncology Research (4 papers), Kruppel-like factors research (4 papers), Vector-borne infectious diseases (4 papers), Epigenetics and DNA Methylation (4 papers) and Neuroblastoma Research and Treatments (4 papers). The work is most often cited by research in Obstetrics and Gynecology (158 citations), Cancer Research (273 citations), Molecular Biology (1.2k citations), Oncology (416 citations) and Reproductive Medicine (128 citations). Michael G. Gartside has collaborated with scholars based in Australia, United States and United Kingdom. Frequent co-authors include Pamela M. Pollock, Nicholas K. Hayward, Paul J. Goodfellow, Sara A. Byron, Matthew A. Powell, Candice L. Wellens, Graham F. Kay, Moosa Mohammadi, Mary A. Mallon and Christine Biondi. Their work appears in journals such as International Journal of Cancer, Parasitology Research, Cancer Research, Oncogene and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact